Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 3.24 Delayed Data As of Feb 21 |  +0.13 / +4.18%Today’s Change | 2.25 Today|||52-Week Range 8.24 | -15.62% Year-to-Date |
Latest ALPN News | Press Releases
No recent news for Alpine Immune Sciences Inc.
Today’s Trading
| Previous close | 3.11 |
| Today’s open | 3.22 |
| Day’s range | 3.19 - 3.25 |
| Volume | 7,387 |
| Average volume (3 months) | 23,340 |
| Market cap | $84.9M |
Data as of 3:59pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | -119.54% |
| Earnings growth (this year) | +3.42% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -59.27% |
| P/E ratio | NM |
| Price/Sales | 72.29 |
| Price/Book | 1.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTEPolarityTE Inc | -0.06 | -3.64% |
| MREOMereo BioPharma Grou... | +0.08 | +3.45% |
| GNCAGenocea Biosciences ... | 0.00 | 0.00% |
| AQBAquaBounty Technolog... | +0.09 | +5.23% |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $705.0K |
| Annual profit (last year) | -$36.5M |
| Net profit margin | -5,175.46% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
